Usnic Acid Derivatives as Multi‐Target Anti‐Alzheimer's Disease Agents: Design, Synthesis, X‐Ray Single Crystal Structure of Zn(II) Complex and Biological Activities
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202401548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Lihua Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Energy and Chemical Engineering, Tianjin Renai College, Tianjin, 301636, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Cholinesterase Inhibitors, Drug Design, Coordination Complexes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is multifactorial, which makes the design of multi‐target‐directed ligands an attractive strategy for the development of anti‐AD drugs. In order to enhance the anti‐AD effects and reduce the toxicity, two usnic acid (UA) derivatives ( 1–2 ) were designed, synthesized and fully characterized by introducing dimethylamine Schiff base moiety into the toxic “triketone” portion. Ellman's method and molecular docking were used to test the cholinesterase inhibitory activities. Antioxidant activities were studied with Fenton reaction, cyclic voltammetry and C. elegans . The results showed that compared with UA, 1–2 had stronger anti‐cholinesterase activities and similar antioxidant activities. Notably, solvent evaporation of 2 and ZnCl 2 formed a single crystal, which was revealed to be a Zn(II) complex with UA and tertiary amine as mixed ligands by X‐ray diffraction. The hydrolysis of 2 was thus furtherly studied by HPLC. Furthermore, the crystal structure supported the replacement of toxic “triketone” moiety in the chelation process, playing a detoxifying role and at the same time regulating metal homeostasis. In silico prediction also showed low hepatotoxicity and acceptable drug‐likeness of 1–2 . Overall, this work provided useful insights into multi‐target anti‐AD candidates with the natural product UA as the lead compound.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Energy and Chemical Engineering, Tianjin Renai College, Tianjin, 301636, China.
- College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
ORCID-Profile: Lin Zheng
Zitieren
APA
Zhao, L., Li, B., & Zheng, L. (2025). Usnic Acid Derivatives as Multi‐Target Anti‐Alzheimer's Disease Agents: Design, Synthesis, X‐Ray Single Crystal Structure of Zn(II) Complex and Biological Activities. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401548
Vancouver
Zhao L, Li B, Zheng L. Usnic Acid Derivatives as Multi‐Target Anti‐Alzheimer's Disease Agents: Design, Synthesis, X‐Ray Single Crystal Structure of Zn(II) Complex and Biological Activities. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401548
BibTeX
@article{Zhao2025,
author = {Zhao, Lihua and Li, Bingbing and Zheng, Lin},
title = {Usnic Acid Derivatives as Multi‐Target Anti‐Alzheimer's Disease Agents: Design, Synthesis, X‐Ray Single Crystal Structure of Zn(II) Complex and Biological Activities},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202401548}
}
EUVIMED